STAT6 and fatty liver disease: Inhibit T-box (T-bet) in T cells and increase the activation of transcription 6 (STAT6) phosphorylation, thus regulating the Th1/Th2 response, inhibiting pro-inflammatory cytokines expression and reversing hepatic steatosis.